Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05  •  04:00PM ET
0.8419
Dollar change
-0.0038
Percentage change
-0.45
%
Index- P/E- EPS (ttm)-1.33 Insider Own41.55% Shs Outstand23.81M Perf Week0.32%
Market Cap24.23M Forward P/E- EPS next Y-0.95 Insider Trans0.10% Shs Float16.83M Perf Month15.17%
Enterprise Value21.62M PEG- EPS next Q-0.24 Inst Own5.74% Short Float3.74% Perf Quarter-35.73%
Income-28.61M P/S115.38 EPS this Y20.13% Inst Trans-2.22% Short Ratio0.21 Perf Half Y-44.79%
Sales0.21M P/B- EPS next Y20.17% ROA-266.75% Short Interest0.63M Perf YTD-41.13%
Book/sh-0.32 P/C6.81 EPS next 5Y- ROE- 52W High2.27 -62.91% Perf Year-60.84%
Cash/sh0.12 P/FCF- EPS past 3/5Y-581.66% - ROIC- 52W Low0.64 31.55% Perf 3Y-91.43%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin-294.23% Volatility4.74% 8.33% Perf 5Y-
Dividend TTM- EV/Sales102.96 EPS Y/Y TTM-9.71% Oper. Margin-9812.02% ATR (14)0.07 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.46 Sales Y/Y TTM-25.18% Profit Margin-13755.29% RSI (14)56.08 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.64 EPS Q/Q5.26% SMA2012.00% Beta2.07 Target Price7.00
Payout- Debt/Eq- Sales Q/Q-25.00% SMA504.24% Rel Volume0.02 Prev Close0.85
Employees42 LT Debt/Eq- EarningsNov 10 BMO SMA200-33.48% Avg Volume2.96M Price0.84
IPOApr 29, 2021 Option/ShortNo / Yes EPS/Sales Surpr.-45.83% -30.00% Trades Volume58,233 Change-0.45%
Date Action Analyst Rating Change Price Target Change
Jun-24-24Initiated Ascendiant Capital Markets Buy $8.50
Dec-04-25 08:00AM
Dec-03-25 12:00PM
Dec-02-25 08:00AM
Nov-20-25 08:00AM
Nov-18-25 08:00AM
09:40AM Loading…
Nov-10-25 09:40AM
08:00AM
Nov-06-25 06:15PM
10:00AM
Nov-05-25 08:15AM
Nov-04-25 09:15AM
08:00AM
Oct-29-25 08:00AM
Oct-28-25 05:15PM
Oct-27-25 08:00AM
09:55AM Loading…
Oct-20-25 09:55AM
Oct-09-25 04:05PM
Oct-08-25 07:00AM
07:00AM
Oct-07-25 08:00AM
07:46AM
Oct-01-25 08:00AM
Sep-25-25 08:00AM
Sep-24-25 08:00AM
Sep-22-25 08:00AM
Sep-19-25 08:00AM
Sep-10-25 08:00AM
Sep-09-25 08:00AM
Sep-08-25 08:00AM
Sep-03-25 08:00AM
08:00AM Loading…
Aug-26-25 08:00AM
07:46AM
Aug-20-25 08:00AM
Jul-31-25 10:30AM
08:00AM
Jul-15-25 04:58PM
Jul-08-25 08:00AM
Jul-01-25 08:00AM
Jun-26-25 08:00AM
Jun-13-25 08:35AM
Jun-11-25 08:30AM
Jun-10-25 02:38PM
08:30AM
May-13-25 09:15AM
May-01-25 12:30PM
Apr-22-25 06:00AM
Mar-31-25 09:15AM
Mar-17-25 09:25AM
Mar-12-25 09:00AM
Mar-10-25 09:00AM
Feb-24-25 09:25AM
Feb-14-25 09:15AM
Dec-19-24 09:00AM
Dec-16-24 09:00AM
Nov-14-24 08:38AM
Nov-12-24 09:25AM
Nov-08-24 09:25AM
Nov-01-24 08:00AM
Oct-24-24 08:00AM
Oct-23-24 08:00AM
Oct-22-24 08:00AM
Oct-01-24 08:00AM
Sep-23-24 08:00AM
Sep-16-24 09:00AM
Aug-28-24 08:00AM
Aug-12-24 08:34AM
Jul-31-24 08:00AM
Jul-01-24 08:00AM
Jun-11-24 08:00AM
Jun-06-24 09:00AM
Jun-05-24 08:00AM
May-15-24 10:53PM
04:05PM
Apr-29-24 09:00AM
Apr-24-24 08:00AM
Apr-03-24 08:05AM
Apr-02-24 10:53PM
08:00AM
Mar-12-24 10:52AM
Mar-04-24 09:20AM
Feb-07-24 09:00AM
Feb-05-24 11:00AM
Jan-30-24 08:05AM
Jan-22-24 09:30AM
09:00AM
Dec-04-23 08:15AM
Nov-20-23 07:30AM
Nov-10-23 09:00AM
Nov-01-23 07:00AM
Oct-31-23 07:00AM
Oct-24-23 09:00AM
Oct-19-23 08:00AM
Oct-10-23 08:30AM
Oct-03-23 08:00AM
Oct-02-23 07:00AM
Jan-01-01 12:00AM
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. It focuses on designing, developing, and marketing fully implantable medical devices that improve hearing. The company was founded in 1995 and is headquartered in White Bear Lake, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel Mona ChetanDirectorJun 11 '25Buy1.472,5003,67520,000Jun 13 04:10 PM
Patel Mona ChetanDirectorJun 06 '25Buy1.4610,00014,60017,500Jun 10 04:11 PM
BRYNELSEN CHARLESDirectorMay 27 '25Buy1.6535,00057,67350,000May 27 06:34 PM
BRYNELSEN CHARLESDirectorMay 23 '25Buy1.6413,00021,36315,000May 27 06:34 PM
BRYNELSEN CHARLESDirectorMay 22 '25Buy1.682,0003,3672,000May 27 06:34 PM